Symbol | YTM % | Wolumen | Cena % | Kupon % | Termin zapadalności | Kwota niezapłacona | Wartość nominalna | Min. kw. nominału | Emitent |
---|---|---|---|---|---|---|---|---|---|
UUS66989HAS7NOVARTIS CAP 20/50 | 6,50% | 0 | 64,01% | 2,75% | 2050-08-14 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
XXPNDNOVARTIS CAPITAL 15/45 | 5,85% | 0 | 82,65% | 4,00% | 2045-11-20 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
NNVS5894401Novartis Capital Corp. 4.7% 18-SEP-2054 | 5,72% | 5,3 M | 88,81% | 4,70% | 2054-09-18 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
UUS66989HAH1NOVARTIS CAPITAL 14/44 | 5,70% | 0 | 88,11% | 4,40% | 2044-05-06 | 1,85 B USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
NNVS3904288Novartis Capital Corp. 3.7% 21-SEP-2042 | 5,69% | 200 K | 82,52% | 3,70% | 2042-09-21 | 500 M USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
NNVS5894400Novartis Capital Corp. 4.2% 18-SEP-2034 | 5,24% | 4,5 M | 93,36% | 4,20% | 2034-09-18 | 1,1 B USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
UUS66989HAR9NOVARTIS CAP 20/30 | 5,06% | 0 | 87,73% | 2,20% | 2030-08-14 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
NNVS5894399Novartis Capital Corp. 4.0% 18-SEP-2031 | 4,91% | 6,09 M | 95,49% | 4,00% | 2031-09-18 | 850 M USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
NNVS5894398Novartis Capital Corp. 3.8% 18-SEP-2029 | 4,73% | 4,36 M | 96,50% | 3,80% | 2029-09-18 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
XXPNCNOVARTIS CAPITAL 15/25 | 4,59% | 0 | 98,84% | 3,00% | 2025-11-20 | 1,75 B USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
UUS66989HAN8NOVARTIS CAPITAL 17/27 | 4,56% | 0 | 97,03% | 3,10% | 2027-05-17 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
NNVS4950565Novartis Capital Corp. 2.0% 14-FEB-2027 | 4,48% | 222 K | 95,48% | 2,00% | 2027-02-14 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
XXS176904160NOVARTIS FIN. 18/38 | 3,49% | 0 | 83,59% | 1,70% | 2038-08-14 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | Novartis Finance SA |
XXS176904119NOVARTIS FIN. 18/30 | 2,84% | 0 | 93,06% | 1,38% | 2030-08-14 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | Novartis Finance SA |
XXS223599621NOVARTIS FI. 20/28 | 2,73% | 0 | 91,05% | 0,00% | 2028-09-23 | 1,85 B EUR | 1 000,00 EUR | 100 000,00 EUR | Novartis Finance SA |
XXS149282548NOVARTIS FIN. 16/28 | 2,54% | 0 | 93,71% | 0,63% | 2028-09-20 | 500 M EUR | 1 000,00 EUR | 100 000,00 EUR | Novartis Finance SA |
NNOJANOVARTIS FIN. 17/27 | 2,45% | 0 | 96,76% | 1,13% | 2027-09-30 | 600 M EUR | 1 000,00 EUR | 100 000,00 EUR | Novartis Finance SA |
XXS113472979NOVARTIS FIN. 14/26 | 2,38% | 0 | 98,75% | 1,63% | 2026-11-09 | 600 M EUR | 1 000,00 EUR | 100 000,00 EUR | Novartis Finance SA |
1,16% | 0 | 113,09% | 1,85% | 2049-06-18 | 190 M CHF | 5 000,00 CHF | 5 000,00 CHF | Novartis AG | |
1,15% | 0 | 109,12% | 1,85% | 2040-06-18 | 280 M CHF | 5 000,00 CHF | 5 000,00 CHF | Novartis AG | |
1,14% | 0 | 99,17% | 1,05% | 2035-05-11 | 325 M CHF | 5 000,00 CHF | 5 000,00 CHF | Novartis AG | |
1,01% | 0 | 106,33% | 1,75% | 2034-06-16 | 645 M CHF | 5 000,00 CHF | 5 000,00 CHF | Novartis AG | |
0,87% | 0 | 104,67% | 1,65% | 2031-06-18 | 435 M CHF | 5 000,00 CHF | 5 000,00 CHF | Novartis AG | |
0,83% | 0 | 99,06% | 0,63% | 2029-11-13 | 550 M CHF | 5 000,00 CHF | 5 000,00 CHF | Novartis AG | |
0,65% | 0 | 102,19% | 1,60% | 2027-06-18 | 650 M CHF | 5 000,00 CHF | 5 000,00 CHF | Novartis AG | |
0,45% | 0 | 99,96% | 0,25% | 2025-05-13 | 500 M CHF | 5 000,00 CHF | 5 000,00 CHF | Novartis AG |